| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | 0.0095 | 0.9 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.0021 | 0.9 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | -0.0021 | 0.9 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.0018 | 1 |